|
All patients
|
mRS 0–2 (n = 32)
|
mRS 3–6 (n = 28)
|
P
|
---|
Age
|
71.2±11.8
|
68.4±11.3
|
74.4±11.6
|
0.04
|
Male sex
|
34 (56.7%)
|
23 (71.9%)
|
11 (39.3%)
|
0.01
|
Hypertension
|
39 (65.0%)
|
19 (59.4%)
|
20 (71.4%)
|
0.33
|
Diabetes mellitus
|
22 (36.7%)
|
11 (34.4%)
|
11 (39.3%)
|
0.69
|
Hyperlipidemia
|
33 (55.0%)
|
17 (53.1%)
|
16 (57.1%)
|
0.76
|
Atrial fibrillation
|
37 (61.7%)
|
16 (50.0%)
|
21 (75.0%)
|
0.046
|
tPA administration
|
16 (26.7%)
|
7 (21.9%)
|
9 (32.1%)
|
0.37
|
NIHSS
|
16.3±6.9
|
15.1±6.3
|
17.7±7.5
|
0.18
|
Stroke subtype
| | | |
0.59
|
Cardioembolism
|
43 (71.7%)
|
22 (68.8%)
|
21 (75.0%)
| |
Large-artery atherosclerosis
|
10 (16.7%)
|
5 (15.6%)
|
5 (17.9%)
| |
Others
|
7 (11.7%)
|
5 (15.6%)
|
2 (7.1%)
| |
ICA/M1 occlusion
|
44 (73.3%)
|
23 (71.9%)
|
21 (75.0%)
|
0.78
|
Procedure time
| | | | |
Onset-to-puncture (min)
|
210 (138, 360)
|
239 (144, 418)
|
203 (134, 278)
|
0.30
|
Onset-to-recanalized (min)
|
234 (156, 391)
|
259 (159, 439)
|
215 (144, 336)
|
0.37
|
mTICI 2c-3
|
43 (71.7%)
|
27 (84.4%)
|
16 (57.1%)
|
0.02
|
Neuroimaging
| | | | |
ASPECTS
|
8 (7, 9)
|
9 (7, 9)
|
8 (7, 10)
|
0.38
|
Initial core (ml)
|
20 (6, 38)
|
14 (3, 26)
|
26 (12, 47)
|
0.03
|
Penumbra (ml)
|
64 (32, 89)
|
57 (32, 79)
|
65 (43, 102)
|
0.40
|
Final infarct (ml)
|
13.9 (3.8, 61.4)
|
8.7 (1.7, 22.4)
|
24.5 (6.5, 139.1)
|
0.01
|
Outcome
| | | | |
mRS score
|
2 (1, 4)
|
1 (1, 2)
|
5 (4, 5)
|
<0.001
|
Mortality
|
4 (6.7%)
|
0 (0%)
|
4 (14.3%)
|
0.04
|
Any ICH
|
20 (33.3%)
|
9 (28.1%)
|
11 (39.3%)
|
0.36
|
Hemorrhagic infarct
|
14 (23.3%)
|
7 (21.9%)
|
7 (25.0%)
|
0.78
|
Parenchymal hemorrhage
|
6 (10.0%)
|
2 (6.3%)
|
4 (14.3%)
|
0.40
|
- The Mann–Whitney U test was used for the continuous variables, whereas the chi-square test was used for the categorical variables. Bold type indicates significant results (P < 0.05)
- ASPECTS Alberta Stroke Program Early CT Score, ICA internal carotid artery, ICH intracerebral hemorrhage, mRS modified Rankin Scale, mTICI modified Thrombolysis in Cerebral Infarction, NIHSS National Institute of Health Stroke Scale, tPA tissue-type plasminogen activator